Testing a PrEP Intervention for Women in Trauma Treatment

Principal Investigator: Angela M. Heads, PhD and Ron Acierno, PhD

Study Contact

Name: Kaixuan An

Email Address: [email protected]

Phone Number: (713) 486-2531

This study is currently looking for people who:

• Are women (assigned female at birth, identify as a woman)
• Are currently undergoing treatment for something traumatic that happened to them
• Can speak and read English
• Are HIV Negative
• Have been sexually active with a man within the past 6 months

Study Description:

The goal of this study is to test a behavioral intervention tailored to help women acquire the knowledge and skills needed to protect themselves from HIV. The intervention includes virtual sessions and an in-clinic visit with a nurse practitioner. Additionally, a mobile app component provides information, motivational messages, a platform to ask provider questions, and a tool to track medication adherence. This is a 12-week study that requires 1-2 in-person visits and 30-minute intervention sessions and surveys that can be completed virtually.

To find out if you are eligible, please call us at 713-486-2531 or click on the following link: Study Screening Survey

PrEP is an FDA approved drug and found by the CDC to be 99% effective in preventing acquiring HIV (PrEP will be provided free of charge).

All participants will be compensated for their time.